Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DNM3 |
| Upstream (Parents) |
|---|
| (<<) BMPR1A → DNM3 |
| (<<) CASP5 → DNM3 |
| (<<) CDC42 → DNM3 |
| (<<) CYP1B1 → DNM3 |
| (<<) FGF1 → DNM3 |
| (<<) GSTZ1 → DNM3 |
| (<<) HOXA3 → DNM3 |
| (<<) MAP1B → DNM3 |
| (<<) MMP19 → DNM3 |
| (<<) NFAT5 → DNM3 |
| (<<) SOCS5 → DNM3 |
| (<<) UBE2I → DNM3 |
| (<<) WNT3 → DNM3 |
| Downstream (Children) |
|---|
| DNM3 → ASTN2 (>>) |
| DNM3 → FGF7 (>>) |
| DNM3 → MAP2K5 (>>) |
| DNM3 → MAPK7 (>>) |
